CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
ObjectivesTo assess the impact of RGLS8429 on height-adjusted total kidney volume (htTKV)To characterize the pharmacokinetic (PK) properties...
Phase 1
Jacksonville, Florida, United States and 27 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Jacksonville, Florida, United States and 321 other locations
This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2...
Phase 2
Orlando, Florida, United States and 100 other locations
receptor is known to trigger injury and inflammation in the kidney and is therefore thought to play a role in CKD.Empagliflozin lowers blood...
Phase 2
Jacksonville, Florida, United States and 210 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
Jacksonville, Florida, United States and 943 other locations
The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This...
Phase 3
Jacksonville, Florida, United States and 559 other locations
The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death ve ...
Phase 3
Jacksonville, Florida, United States of America and 239 other locations
The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...
Phase 3
Saint Augustine, Florida, United States and 405 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Fleming Island, Florida, United States and 348 other locations
The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ell...
Jacksonville, Florida, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal